52 related articles for article (PubMed ID: 2833190)
1. Effects of spiraprilic acid, an angiotensin converting enzyme inhibitor, on large artery compliance in anesthetized dogs.
Watkins RW; Sybertz EJ; Antonellis A; Pula K
Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):222-34. PubMed ID: 2833190
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive, hemodynamic and autonomic profile of a new angiotensin converting enzyme inhibitor, SCH 33844 (spirapril).
Baum T; Watkins RW; Sybertz EJ; Ahn HS; Nelson S; Coleman W; Tedesco R; Pula KK; Rivelli M; Sabin C
Arch Int Pharmacodyn Ther; 1987 Apr; 286(2):230-45. PubMed ID: 2884941
[TBL] [Abstract][Full Text] [Related]
3. Effects of the antihypertensive dilevalol on large artery compliance in anesthetized dogs.
Watkins RW; Sybertz EJ; Antonellis A; Pula K; Rivelli M
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S58-63. PubMed ID: 2454369
[TBL] [Abstract][Full Text] [Related]
4. Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
Zhou X; Matavelli LC; Ono H; Frohlich ED
Am J Physiol Renal Physiol; 2005 Oct; 289(4):F871-9. PubMed ID: 15900021
[TBL] [Abstract][Full Text] [Related]
5. Acute hemodynamic effects of the active metabolite of imidapril, (4S)-3-((2S)-2-[N-((1S)-1-carboxy-3-phenyl-propyl)amino]propionyl)-1- methyl-2-oxoimidazolidine-4-carboxylic acid, and enalaprilat in anesthetized dogs.
Ikeo T; Yabana H; Kurosawa H; Kaburaki M; Kikkawa K; Narita H; Murata S; Yamaguchi I
Arzneimittelforschung; 1992 Sep; 42(9):1109-14. PubMed ID: 1332727
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of verapamil, diltiazem and nifedipine on aortic compliance in anesthetized dogs.
Watkins RW; Sybertz EJ; Pula K; Antonellis A
Arch Int Pharmacodyn Ther; 1988; 293():134-42. PubMed ID: 3421772
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic converting enzyme inhibition on the structure and function of large arteries in the rat.
Levy BI; Michel JB; Salzmann JL; Devissaguet M; Camilleri JP; Safar ME
Clin Exp Hypertens A; 1989; 11 Suppl 2():487-98. PubMed ID: 2605798
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin converting enzyme inhibitors: spirapril and related compounds.
Smith EM; Swiss GF; Neustadt BR; McNamara P; Gold EH; Sybertz EJ; Baum T
J Med Chem; 1989 Jul; 32(7):1600-6. PubMed ID: 2544729
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of new angiotensin converting enzyme inhibitors during continuous angiotensin I infusion on conscious dogs.
Hütter JF; Dehn A; Schmidt W
Arzneimittelforschung; 1988 Jul; 38(7):896-901. PubMed ID: 2849951
[TBL] [Abstract][Full Text] [Related]
10. Effects of the new angiotensin-converting enzyme inhibitor imidapril on renal hemodynamics and function in anesthetized dogs.
Nishiyama S; Kanno K; Yoneda H; Yano K; Yamaguchi I
Arzneimittelforschung; 1992 Apr; 42(4):451-6. PubMed ID: 1322673
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
12. Regional vasodilating effects of spirapril diacid and enalapril diacid in anesthetized dogs.
Noguchi K; Ojiri Y; Chibana T; Kinjo N; Moromizato H; Nakasone J; Sakanashi M
Arch Int Pharmacodyn Ther; 1991; 309():51-63. PubMed ID: 1888230
[TBL] [Abstract][Full Text] [Related]
13. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
Freeman JG; Hock CE; Edmonds JS; Lefer AM
J Pharmacol Exp Ther; 1984 Dec; 231(3):610-5. PubMed ID: 6094795
[TBL] [Abstract][Full Text] [Related]
14. Topical ocular hypotensive effects of the novel angiotensin converting enzyme inhibitor SCH 33861 in conscious rabbits.
Watkins RW; Baum T; Cedeno K; Smith EM; Yuen PH; Ahn HS; Barnett A
J Ocul Pharmacol; 1987; 3(4):295-307. PubMed ID: 3503919
[TBL] [Abstract][Full Text] [Related]
15. Comparative hemodynamic effects of MK-422, a converting enzyme inhibitor, and a renin inhibitor in dogs with acute left ventricular failure.
Sweet CS; Ludden CT; Frederick CM; Bush LR; Ribeiro LG
J Cardiovasc Pharmacol; 1984; 6(6):1067-75. PubMed ID: 6084762
[TBL] [Abstract][Full Text] [Related]
16. Superior effect of an angiotensin-converting enzyme inhibitor over a diuretic for reducing aortic systolic pressure.
Jiang XJ; O'Rourke MF; Zhang YQ; He XY; Liu LS
J Hypertens; 2007 May; 25(5):1095-9. PubMed ID: 17414675
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
Laubie M; Schiavi P; Vincent M; Schmitt H
J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
[TBL] [Abstract][Full Text] [Related]
18. Beneficial hemodynamic and renal effects of intravenous enalaprilat following coronary artery bypass surgery complicated by left ventricular dysfunction.
Wagner F; Yeter R; Bisson S; Siniawski H; Hetzer R
Crit Care Med; 2003 May; 31(5):1421-8. PubMed ID: 12771613
[TBL] [Abstract][Full Text] [Related]
19. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
20. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Iijima M; Ushijima T; Kajiwara Y; Kitabatake K
Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
